Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. H. Res. 803. 119th Cong., 1st sess., Introduced in House October 10, 2025. https://www.govinfo.gov/app/details/BILLS-119hres803ih.
Congress, House of Representatives (2025, October 10). Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. (H. Res. 803 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hres803ih.
United States, Congress, House of Representatives. Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hres803ih. 119th Congress, H. Res. 803, Introduced in House 10 Oct. 2025.
H.Res.803 - 119th Congress (2025-2026): Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes., H.Res.803, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119hres803ih.